甲基强的松龙治疗多发性硬化症：不良反应概述
Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects.
作者信息
Lyons P R, Newman P K, Saunders M
机构信息
Department of Neurology, Middlesbrough General Hospital, Cleveland, UK.
出版信息
J Neurol Neurosurg Psychiatry. 1988 Feb;51(2):285-7. doi: 10.1136/jnnp.51.2.285.
Abstract
A retrospective analysis of 350 treatment courses using high dose pulsed intravenous methylprednisolone for relapses of multiple sclerosis revealed a low number of adverse effects. This study confirms that high dose methylprednisolone is a safe therapeutic option in multiple sclerosis.
摘要
一项对350个使用大剂量静脉注射甲基强的松龙治疗多发性硬化症复发疗程的回顾性分析显示，不良反应数量较少。这项研究证实，大剂量甲基强的松龙是治疗多发性硬化症的一种安全的治疗选择。
相似文献
1
Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects.
J Neurol Neurosurg Psychiatry. 1988 Feb;51(2):285-7. doi: 10.1136/jnnp.51.2.285.
2
Oral versus intravenous corticosteroids in acute relapses of multiple sclerosis.
Lancet. 1997 Jun 7;349(9066):1696-7. doi: 10.1016/S0140-6736(05)62664-5.
3
[Comments on the contribution, "Immunomodulating staged therapy of multiple sclerosis by the Multiple Sclerosis Therapy Consensus Group"].
Nervenarzt. 2002 Dec;73(12):1207; author reply 1207.
4
Methylprednisolone in multiple sclerosis: a comparison of oral with intravenous therapy at equivalent high dose.
J Neurol Neurosurg Psychiatry. 1993 Nov;56(11):1219-20. doi: 10.1136/jnnp.56.11.1219.
5
[Steroid therapy for multiple sclerosis].
Nihon Rinsho. 2003 Aug;61(8):1361-6.
6
High-dose methylprednisolone-induced hepatitis in a patient with multiple sclerosis: a case report and brief review of literature.
Neth J Med. 2013 May;71(4):199-202.
7
Incidence of various cardiac arrhythmias and conduction disturbances due to high dose intravenous methylprednisolone in patients with multiple sclerosis.
J Neurol Sci. 2011 Oct 15;309(1-2):75-8. doi: 10.1016/j.jns.2011.07.018. Epub 2011 Aug 9.
8
[Treatment of optic neuritis with corticosteroids. Discussion at the 10th Meeting of the International Neuro-ophthalmological Society (Freiburg 5 to 9 June 1994)].
Klin Monbl Augenheilkd. 1994 Sep;205(3):126-7.
9
Oral versus intravenous methylprednisolone for the treatment of multiple sclerosis relapses: A meta-analysis of randomized controlled trials.
PLoS One. 2017 Nov 27;12(11):e0188644. doi: 10.1371/journal.pone.0188644. eCollection 2017.
10
Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial.
Lancet. 2015 Sep 5;386(9997):974-81. doi: 10.1016/S0140-6736(15)61137-0. Epub 2015 Jun 28.
引用本文的文献
1
Improving Glucocorticoid Sensitivity of Brain-Homing CD4 T Helper Cells by Steroid Hormone Crosstalk.
Front Immunol. 2022 May 26;13:893702. doi: 10.3389/fimmu.2022.893702. eCollection 2022.
2
Use of Intravenous Pulse Steroids to Treat Allergic Bronchopulmonary Aspergillosis in a Non-Compliant Asthmatic Adolescent.
Children (Basel). 2022 Feb 14;9(2):252. doi: 10.3390/children9020252.
3
A review on function and side effects of systemic corticosteroids used in high-grade COVID-19 to prevent cytokine storms.
EXCLI J. 2021 Feb 15;20:339-365. doi: 10.17179/excli2020-3196. eCollection 2021.
4
How to run a multiple sclerosis relapse clinic.
Pract Neurol. 2016 Feb;16(1):62-9. doi: 10.1136/practneurol-2015-001214. Epub 2015 Nov 11.
5
Acute symptomatic sinus bradycardia in a woman treated with pulse dose steroids for multiple sclerosis: a case report.
J Med Case Rep. 2015 Sep 24;9:216. doi: 10.1186/s13256-015-0701-x.
6
VBP15, a novel anti-inflammatory, is effective at reducing the severity of murine experimental autoimmune encephalomyelitis.
Cell Mol Neurobiol. 2015 Apr;35(3):377-387. doi: 10.1007/s10571-014-0133-y. Epub 2014 Nov 13.
7
Updates on clinically isolated syndrome and diagnostic criteria for multiple sclerosis.
Neurohospitalist. 2013 Apr;3(2):65-80. doi: 10.1177/1941874412457183.
8
Multiple sclerosis, relapses, and the mechanism of action of adrenocorticotropic hormone.
Front Neurol. 2013 Mar 8;4:21. doi: 10.3389/fneur.2013.00021. eCollection 2013.
9
Potential immunological consequences of pharmacological suppression of gastric acid production in patients with multiple sclerosis.
BMC Med. 2012 Jun 7;10:57. doi: 10.1186/1741-7015-10-57.
10
Deferiprone modulates in vitro responses by peripheral blood T cells from control and relapsing-remitting multiple sclerosis subjects.
Int Immunopharmacol. 2011 Nov;11(11):1796-801. doi: 10.1016/j.intimp.2011.07.007. Epub 2011 Jul 30.
本文引用的文献
1
Epilepsy and disseminated sclerosis.
Q J Med. 1962 Apr;31:141-55.
2
The electroencephalogram of multiple sclerosis; a preliminary report.
Dis Nerv Syst. 1959 Jan;20(1):41-4.
3
Fatal arrhythmia after pulse methylprednisolone therapy.
Ann Intern Med. 1981 Dec;95(6):781-2. doi: 10.7326/0003-4819-95-6-781_3.
4
Methylprednisolone therapy in multiple sclerosis.
J Neurol Neurosurg Psychiatry. 1982 Oct;45(10):941-2. doi: 10.1136/jnnp.45.10.941.
5
Treatment of acute exacerbations of multiple sclerosis with intravenous methyl-prednisolone.
J Neurol Neurosurg Psychiatry. 1982 Feb;45(2):179-80. doi: 10.1136/jnnp.45.2.179-a.
6
Possible beneficial effect of high-dose intravenous steroid therapy in acute demyelinating disease and transverse myelitis.
Neurology. 1980 Jul;30(7 Pt 2):33-6. doi: 10.1212/wnl.30.7_part_2.33.
7
Cyclosporin A, methylprednisolone, and convulsions.
Lancet. 1982 Oct 9;2(8302):829-30. doi: 10.1016/s0140-6736(82)92727-1.
8
A double-blind placebo-controlled trial of methylprednisolone pulse therapy in active rheumatoid disease.
Lancet. 1982 Jul 31;2(8292):237-40. doi: 10.1016/s0140-6736(82)90323-3.
9
Intravenous methylprednisolone sodium succinate: adverse reactions reported in association with immunosuppresive therapy.
Transplant Proc. 1973 Jun;5(2):1145-6.
10
The effect of massive pulse steroid therapy on the water content of the rat brain.
Transplantation. 1972 Sep;14(3):403-5.
Zotero 插件